Skip to main content
Equibles
BTSG logo

BTSG · BrightSpring Health Services, Inc.

Track BTSG — free

Use BTSG with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$59.85 -0.40 (-0.66%)
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$11.92B
Shares
197.86M

BTSG metrics

84 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$60.25
Market cap
$11.92B

Price action

19 metrics
Price change (1W)
+3.4%
Price change (30D)
-2.2%
Price change (3M)
-0.3%
Price change (6M)
+45.5%
Price change (YTD)
+58.0%
Price change (1Y)
+149.7%
Trailing year
Price change (5Y)
—
52-week high
$72.91
52-week low
$23.88
Change from 52-week high
-18.9%
Change from 52-week low
+147.7%
Annualized volatility
44.6%
Beta
1.4
RSI (14D)
43.9
Price vs SMA 50
-9.7%
Price vs SMA 200
+19.1%
Avg volume (3M)
3.75M
Relative volume
0.4
Average dollar volume
$243.82M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
197.86M

Valuation

12 metrics
P / E (TTM)
35.9
Trailing earnings · reciprocal yield 2.8%
PEG ratio
0.2
EV / revenue
0.9×
reciprocal yield 108.9%
EV / EBITDA
21.7×
reciprocal yield 4.6%
EV / EBIT
29.5×
reciprocal yield 3.4%
P / sales
0.8×
reciprocal yield 124.4%
P / book
5.6
reciprocal yield 17.7%
FCF yield
3.5%
TTM · current market cap
Buyback yield
—
P / FCF
28.7
reciprocal yield 3.5%
P / operating cash flow
22.8
reciprocal yield 4.4%
Earnings yield
3.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.7×
reciprocal yield 144.3%
EV / revenue historical average (5Y)
0.7×
reciprocal yield 144.3%
EV / EBIT historical average (3Y)
30.6×
reciprocal yield 3.3%
EV / EBIT historical average (5Y)
30.6×
reciprocal yield 3.3%
EV / EBITDA historical average (3Y)
16.5×
reciprocal yield 6.1%
EV / EBITDA historical average (5Y)
16.5×
reciprocal yield 6.1%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-31

Profitability

9 metrics
Gross margin
12.4%
Operating margin
3.1%
Trailing 12 months
Net margin
2.5%
Gross profit (TTM)
$1.78B
Operating profit (TTM)
$447.80M
Net income (TTM)
$365.97M
Trailing 12 months
Diluted EPS (TTM)
$1.65
FCF margin
2.8%
Effective tax rate
16.1%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$4.96

Growth

11 metrics
Revenue growth YoY
+23.0%
Year over year
Net income growth YoY
+198.8%
Revenue (TTM)
$14.37B
Trailing 12 months
EPS growth YoY
+192.3%
Shares change YoY
+1.8%
Year over year · more shares
Revenue CAGR (3Y)
+18.7%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
17.9%
Return on assets
6.1%
Debt / equity
1.1
Current ratio
1.6
EBITDA (TTM)
$608.59M
Free cash flow (TTM)
$402.35M
Quick ratio
1.2
Interest coverage
2.9
Net debt / EBITDA
2.7
Return on invested capital
10.2%
Trailing 12 months
Net cash
−$1.64B
Latest balance sheet
Cash & equivalents
$550.38M
Total assets
$5.99B
Total debt
$2.19B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$506.35M
Capital expenditures (TTM)
$104.00M
R&D (TTM)
—
SG&A (TTM)
$1.33B
Stock compensation (TTM)
$54.78M
R&D / revenue
—
Stock compensation / revenue
0.4%

Ownership (13F)

3 metrics
13F filers
439
13F filer change QoQ
+86
Institutional ownership
106.8%

Short interest

3 metrics
Short interest
4.5%
Latest settlement · 2.9 days to cover
Days to cover
2.9d
Short-squeeze score
55 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.73B
Insider-sentiment score
2 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1865782 CUSIP 10950A106 13F (30d) 329 filings 327 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)